Authors: Swaak, AJG van de Brink, H Smeenk, RJT Manger, K Kalden, JR Tosi, S Marchesoni, A Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Dratwianka, B Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS

Citation: Ajg. Swaak et al., Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT), RHEUMATOLOG, 40(1), 2001, pp. 89-94

Authors: Swaak, AJG van den Brink, HG Smeenk, RJT Manger, K Kalden, JR Tosi, S Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS

Citation: Ajg. Swaak et al., Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation, LUPUS, 10(1), 2001, pp. 51-58

Authors: Herak-Perkovic, V Grabarevic, Z Banic, M Anic, B Novosel, V Pogacnik, M

Citation: V. Herak-perkovic et al., Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice, J VET PHARM, 24(4), 2001, pp. 267-273